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Background: Src homology 2 (SH2) domains are known to specifically bind to phosphotyrosine followed by a few amino
acids.
Results:A novel interaction region was revealed by the solution structure of the C-terminal Src kinase SH2 domain in complex
with the Csk-binding protein.
Conclusion: The novel interaction region was required for tumor suppression.
Significance: The structure sheds new light on the interaction mode of SH2 domains.
Proteins with Src homology 2 (SH2) domains playmajor roles
in tyrosine kinase signaling. Structures of many SH2 domains
have been studied, and the regions involved in their interactions
with ligands have been elucidated.However, these analyses have
been performed using short peptides consisting of phosphoty-
rosine followed by a few amino acids, which are described as the
canonical recognition sites. Here, we report the solution struc-
ture of the SH2 domain of C-terminal Src kinase (Csk) in com-
plex with a longer phosphopeptide from the Csk-binding
protein (Cbp). This structure, together with biochemical exper-
iments, revealed the existence of a novel binding region in addi-
tion to the canonical phosphotyrosine 314-binding site of Cbp.
Mutational analysis of this second region in cells showed that
both canonical and novel binding sites are required for tumor
suppression through theCbp-Csk interaction. Furthermore, the
data indicate an allosteric connection between Cbp binding and
Csk activation that arises from residues in theB/C loop of the
SH2 domain.
Src homology 2 (SH2)3 domains are noncatalytic regions
commonly observed in various types of signal transduction pro-
teins. They function as modules that mediate the interaction
between proteins by recognizing a phosphotyrosine (Tyr(P)) in
the target proteins. Structural and quantitative binding analy-
ses ofmany SH2 domains in complexes with related ligand pep-
tides have shown that SH2 domains generally recognize Tyr(P)
with three amino acid residues toward the C terminus (Tyr(P)-
Xaa1-Xaa2-Xaa3) of the target ligands using two recognition
pockets on the surface of the SH2 domains (1–4). One pocket
recognizes Tyr(P) of the target primarily through electrostatic
interactions and hydrogen bonds, whereas the other recognizes
the remaining three amino acids (Xaa1-Xaa2-Xaa3) specifically
through hydrophobic interactions. This specificity is consid-
ered to generate versatility in the interaction of SH2domains (5,
6). However, it is still controversial whether the latter pocket
alone is sufficient to determine the specificity of the associated
interactions (4, 7).
The protein C-terminal Src kinase (Csk) includes SH3, SH2,
and kinase domains. This kinase specifically phosphorylates a
regulatory Tyr in the C-terminal tail of Src Tyr kinases (SFKs)
(8, 9). This event leads to an intramolecular interaction between
the Tyr(P)-containing tail and the SH2 domain of the phosphor-
ylated SFK, shifting it to an inactive closed conformation. Thus,
Csk negatively regulates the kinase activity of SFKs and plays an
important role in physiological functions via signaling path-
ways for cell proliferation, differentiation, adhesion, andmigra-
tion (10).
Although SFKs are anchored to membranes via their fatty-
acylated N termini, Csk, which lacks such a fatty acylation site,
exists in the cytoplasm (9). Thus, for Csk to efficiently access
SFKs, Csk interacts with the Csk-binding protein (Cbp/PAG),
which is localized to membrane microdomains enriched in
cholesterol, glycosphingolipids, and lipid rafts, and it is subse-
quently recruited to the reaction space (11, 12). This interaction
is known to occur between the SH2 domain of Csk and the
SFK-phosphorylated Tyr-314 of Cbp, but it remains unknown
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whether any other region in Cbp is involved in the interaction
(13). In addition, unlike SFKs, which conserve specific Tyr in
their C-terminal tails for regulating activity, Csk lacks such a
functional tail (9). Nevertheless, the crystal structure of Csk by
itself exhibited the existence of two conformers corresponding
to active and inactive forms (14). The mechanism of Csk acti-
vation is described in detail in a previous review (15). The SH2
domain appears to be required for stabilizing the active form of
Csk through connection between the B/C loop (SH2) and
the3/C loop (kinase). It was also reported that Csk activity is
increased through interactions with phosphorylated Cbp or its
peptides (13, 16–19). Therefore, it can be speculated that Cbp
binding shifts the dynamic equilibrium of at least these two
conformers to the more active form. However, the mechanism
through which Cbp binding increases Csk activity remains
unclear.
To elucidate these mechanisms, we first analyzed the inter-
action of Csk with various lengths of Tyr-314-containing
regions of Cbp using gel filtration chromatography. On the
basis of this biochemical result, we determined the tertiary
solution structure of the complex of Csk-SH2 with a region of
Cbp that contained both Tyr-296 and Tyr(P)-314 using liquid-
state nuclear magnetic resonance (NMR) spectroscopy. We
found that Csk recognizes not only the four canonical amino
acids beginning with Tyr(P)-314 but also a region on the N-ter-
minal side of Tyr(P)-314 that contains Tyr-296.
EXPERIMENTAL PROCEDURES
Preparation of Cbp Mutants—The DNA fragment for rat
Cbp peptide (from 289 to 321; Cbp5) was amplified using the
pGEX-6P-1 plasmid (GEHealthcare) containing theDNA frag-
ment encoding the region from 195 to 328 of Cbp (Cbp3) by
PCRusing 5-CGCGGATCCAAGAGATTTAGTTCCTTG
TCA-3 and 5-GGC GAA TTC CTA TCC AGG CTT ATT
CAC TGA AGA-3 as primers (Fig. 1A). The amplified DNA
fragment was cleaved with BamHI and EcoRI, and the resulting
gene was inserted into the BamHI-EcoRI site of pGEX-6P-1.
The pGEX-6P-1 plasmid containing the DNA fragment encod-
ing the region from 302 to 321 of Cbp (Cbp6) or a mutant of
Cbp5 (Y296F) was produced by the same method as described
above using the following primers: 5-CGC GGA TCC CCA
ACT CTT ACA GAA GAG GAG-3 and 5-GGC GAA TTC
CTA TCC AGG CTT ATT CAC TGA AGA-3 for Cbp6 and
5-CGCGGATCCAAGAGATTTAGTTCCTTGTCATTC
AAG TCT CGA-3 and 5-GGC GAA TTC CTA TCC AGG
CTTATTCACTGAAGA-3 for Cbp5-Y296F. TheDNA frag-
ment encoding the region from 312 to 321 of Cbp (Cbp7) was
amplified by annealing 5-GATCC ATG TAT TCT TCA GTG
AAT AAG CCT GGA TAG G-3 and 5-ATTTC CTA TCC
AGG CTT ATT CAC TGA AGA ATA CAT G-3, and the
amplified DNA fragment was inserted into the BamHI-EcoRI
site of pGEX-6P-1. For a doubly phosphorylated Tyr(P)-296/
Tyr(P)-314 peptide, a synthetic product (TORAY) was used.
Expression and Purification of Various Cbp Peptides—Esche-
richia coli BL21(DE3) cells were transformed with pGEX-6P-1
containing DNA encoding each of the Cbp peptides and grown
in LB media. The cells were incubated at 25 °C with shaking at
240 rpm for 12 h. The expression of GST-fused Cbp peptides
was induced by addition of isopropyl -D-thiogalactopyrano-
side to a final concentration of 0.1 mM when the absorbance at
600 nm was between 0.3 and 0.6. The cells were further incu-
bated overnight, harvested by centrifugation, and stored at
80 °C. For purification, the cells were dissolved at 4 °C and
disrupted by sonication in 100 mM Tris-HCl buffer (pH 7.4)
containing 150 mM NaCl, 1 mM EDTA, 5 mM -mercaptoetha-
nol, and 1% Nonidet P-40 (lysis buffer). After centrifugation,
the supernatant was applied to the GSTrap FF affinity column
(GE Healthcare), and adsorbed proteins were eluted using lysis
buffer (pH 9.0) containing 20mM reduced glutathione. All puri-
fied GST-Cbp fusion proteins were phosphorylated using
recombinant Fyn (Millipore) in 50mMTris-HCl buffer (pH 7.4)
containing 3 mM MgCl2, 1 mM -mercaptoethanol, and 4 mM
ATP.
Expression and Purification of Csk—Full-length (amino acids
1–450) rat Csk was expressed using a baculovirus vector in Sf9
insect cells, as described previously (13). Cells were lysed using
the above-mentioned lysis buffer containing EDTA-free prote-
ase inhibitor mixture (Nacalai Tesque) and disrupted using a
Dounce homogenizer. The supernatant was collected by cen-
trifugation and applied to the HiTrap Q HP anion exchange
column (GE Healthcare) equilibrated with 50 mM Tris-HCl
buffer (pH 8.0) containing 1 mM EDTA, 5% glycerol, 5 mM
-mercaptoethanol, and 0.02% octyl-D-glucoside (buffer A).
The protein was eluted with a linear gradient of 75–300 mM
NaCl. Protein-containing fractions were applied to the HiTrap
SP HP cation exchange column (GE Healthcare) equilibrated
with buffer A. The protein, eluted with a linear gradient of
50–300mMNaCl, was applied to the Superdex 200 gel filtration
column (GE Healthcare).
Expression and Purification of 13C- and 15N-Labeled Csk-
SH2—To obtain 13C- and 15N-labeled proteins, E. coliOrigami
B(DE3) cells were transformed with pGEX-6P-1(GE Health-
care) containing the gene of Csk-SH2 and were grown in M9
minimal medium containing 1.5 g/liter 15NH4Cl and 2.0 g/liter
D-[U-13C6]glucose, as nitrogen and carbon sources, respec-
tively. For the expression of uniformly 15N-labeled proteins,
D-[U-13C6]glucose was replaced with 4.0 g/liter D-glucose, and
0.1% glycerol was added to the minimal medium. Cells were
incubated at 37 °Cwith shaking. The expression of proteinswas
induced by the addition of isopropyl -D-thiogalactopyrano-
side to a final concentration of 0.5 mM when the absorbance of
cells reached an A600 of 0.6. Bacteria were grown for an addi-
tional 3 h at 37 °C. Cells were collected by centrifugation and
disrupted by sonication in 50mMTris-HCl buffer (pH 7.0) con-
taining 400 mMNaCl, 0.1% Tween 20, 1 mM EDTA, and 1ml of
protease inhibitor mixture (Sigma). After centrifugation, the
supernatant solution was passed through the DEAE-Sepharose
anion exchange column (GE Healthcare) to remove contami-
nating nucleic acids. The eluate was applied to the GSTrap FF
column (GE Healthcare), and the proteins were eluted with 50
mM Tris-HCl buffer (pH 8.0) containing 10 mM reduced gluta-
thione. The eluate was dialyzed for a few hours at 4 °C against 2
liters of the sonication buffer. After addition of 20l of PreScis-
sion protease (2 units/l; GE Healthcare) to the solution, it was
further dialyzed over 17 h for cleavage of the fusion proteins. In
some cases, GSTwas cut off by the sameprotease before elution
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of the fusion protein from the GSTrap FF column during over-
night incubation at 4 °C. The proteins were concentrated using
an Amicon ultra-4-centrifugal filter unit (Millipore; molecular
cutoff, 3000) and were applied to the Superdex 75 gel filtration
column (GE Healthcare) with a 20 mM sodium phosphate
buffer solution (pH 6.0) containing 50 mM NaCl. The obtained
protein (Csk-SH2) ranged from Met-80 to Met-173 with a tag
derived from the expression vector (H2N-Gly-Pro-Leu-Gly-
Ser-) attached to the N terminus. Protein concentration was
estimated using absorbance at 280 nm (A280) with the calcu-
lated molar absorption coefficient of 16,000.
Expression and Purification of 13C- and 15N-Labeled Cbp
Peptide—TheCbp5 peptide was expressed in E. coliBL21(DE3)
cells (Takara) as a fusion protein with GST, which was labeled
with 13C- and 15N-stable isotopes. The procedures for expres-
sion and purification were almost the same as those for Csk-
SH2. After elution from the GSTrap FF column, the eluate was
diluted with the same amount of 20 mM Tris-HCl buffer (pH
8.0). The solution was applied to the HiTrap DEAE FF anion
exchange column (GE Healthcare), and the Cbp peptide was
phosphorylated by addition of Fyn andATP prior to removal of
GST. A solution containing Csk-SH2 and Cbp5 was applied to
the gel filtration column, and the fractions containing the com-
plex were collected.
Protein Binding Assays Using Gel Filtration Chromatog-
raphy—Each peptide was mixed with equimolar intact Csk or
Csk-SH2 in 100 mM Tris-HCl buffer (pH 8.5) containing 150
mMNaCl or 1 M (NH4)2SO4, 5% glycerol, 5mM -mercaptoeth-
anol, and 0.02% octyl-D-glucoside with or without ATP. The
solutionwas applied to the Superdex 200HR10/30 (GEHealth-
care) gel filtration column; A280 was monitored, and each frac-
tion was analyzed by SDS-PAGE. The synthesized peptide and
Csk were mixed in a molar ratio of 2:1, and the mixture was
assayed as described above.
NMR Spectroscopy—All NMR spectra were acquired at 298
K, except the three-dimensional aromatic 13C-edited nuclear
Overhauser effect spectroscopy (NOESY), which was per-
formed at 288 K (20), using Bruker DRX-500 and DRX-600
instruments equipped with shielded triple-axis gradient triple-
resonance probes, andDRX-800, AvanceII-800, andAvanceIII-
950 instruments equipped with z axis gradient triple resonance
cryogenic probes. For assignments of 1H, 13C, and 15N reso-
nances, a series of two- and three-dimensional experiments
were performed (21). Two-dimensional 1H-15N heteronuclear
single- quantum correlation (HSQC), three-dimensional
HNCACB, CBCA(CO)NH, HNCA, HN(CO)CA, HNCO,
HN(CA)CO, and HBHA(CBCACO)NH spectra were acquired
for assignment of backbone signals. For assignment of the ali-
phatic side-chain signals, two-dimensional 1H-13C constant
time HSQC, three-dimensional 15N-edited total correlation
spectroscopy (TOCSY) with a mixing time of 79.4 ms, HCCH-
TOCSY with a mixing time of 22.6 ms, and C(CO)NH and
H(CCO)NH with a mixing time of 22.6 ms spectra were used.
For assignment of the aromatic side-chain signals, two-dimen-
sional 1H-1H double-quantum filtered correlation spectros-
copy (22–24) and three-dimensional aromatic 13C-edited
NOESY with a mixing time of 100 ms were used. The chem-
ical shifts of the 1H/ spins in the aromatic residues were
assigned by means of two-dimensional (H)C(CC)H
and (H)C(CCC)H experiments (25). For detection of
intermolecular NOEs, a series of filter-related experiments
were conducted, namely a 13C-filtered/13C-edited NOESY
using 13C,15N-labeled Csk-SH2 complexed with nonlabeled
Cbp5 peptide and a 13C-filtered/13C-edited NOESY and
13C,15N-filtered/15N-edited NOESY using 13C,15N-labeled
Cbp5 peptide complexed with nonlabeled Csk-SH2 (26).
Structure Calculations—The NOE peaks were manually
assigned using Sparky. Distance restraints were generated
according to the assignment of theNOE cross-peaks, and pseu-
do-atom corrections were applied to the upper bound
restraints involving methyl, methylene, and aromatic ring pro-
tons as described previously (27). Torsion angle restraints were
derived using TALOS (28) with the assigned chemical shifts
of 1H, 13C, 13C, 13CO, and 15N, in reference to the x-ray
structure of intact Csk (14). Hydrogen bond restraints, 2.5–3.3
Å for N-O pairs and 1.8–2.3 Å for H-O pairs, were added only
to secondary structural regions as confirmed through the cor-
responding NOE patterns. One disulfide bond between Cys-
122 and Cys-164 was confirmed through characteristic 13C
and 13C chemical shifts (29) and used as a restraint for struc-
ture calculations. Structure calculations with torsion angle
dynamics were performed using CYANA-2.1 (30). A total of
100 structures were calculated with 40,000 steps, and after a
root-mean-square deviation (r.m.s.d.) for the backbone atoms
had reached 1.0 Å, the r6 sum averaging method, originally
implemented in the CYANA calculations, was applied instead
of the pseudo-atom corrections. Finally, the 20 structures with
the lowest target functions were selected. Molecular models
were prepared using MOLMOL (31) and UCSF Chimera (32).
Hydrogen bonds in the complex structure were defined using
UCSF Chimera. An accessible surface area for each residue was
calculated using MOLMOL. The electrostatic potential of the
complex structure was calculated using Delphi (33). All the
amino acid sequence alignments were performed using Clust-
alW, version 2.0 (34).
Relaxation Analysis—The 15N-spin longitudinal (R1) and
transverse (R2) relaxation rates and {1H}–15N steady-stateNOE
values were acquired on Bruker DRX-500 and AvanceII-800
spectrometers (26). R1 relaxation delays were set at 5, 100, 200,
300, 400, 550, 700, 850, 1000, 1150, and 1300 ms, and R2 relax-
ation delays were set at 7.2, 36, 72, 108, 144, 180, 216, 252, 288,
324, and 360 ms in corresponding experiments. Single expo-
nential curve fitting was performed using Sparky (35). The
model-free analysis developed by Lipari and Szabo (36), with
the isotropic rotational diffusion model assumed, was per-
formed using Tensor2 (37). All NMR data were processed and
analyzed using NMRPipe (38) and Sparky, respectively.
zz-Exchange Spectroscopy—Chemical exchange associated
with the interaction wasmonitored using 15N-labeled Csk-SH2
mixed with each of the nonlabeled phosphopeptides, Cbp5,
Cbp6, and Cbp7, at amolar ratio of 2:1 by two-dimensional 15N
zz-exchange spectroscopy (39–41) on a Bruker Avance-III 950
spectrometer with a cryogenic TCI probe. The spectra were
acquired with mixing times, m, of 0, 20, 50, 100, 200, 350, 550,
and 800 ms. For each time point, four peaks observed with
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intensities denoted by IAA(m), IBB(m), IBA(m), and IAB(m)
are, respectively, governed by Equation 1,
IAAm IAA(0)[pA	 pB expkexm] expR1m (Eq. 1)
IBBm IBB(0)[pB	 pA expkexm] expR1m
IBAm IAA(0)[pB(1
 expkexm] expR1m
IABm IBB(0)[pA(1
 expkexm] expR1m
where pi represents the relative population for the site i; kex
represents the sum of the forward, k1, and reverse, koff, kinetic
rate constants for interconversion between the sites; and R1
represents the longitudinal relaxation rate of the 15N nucleus in
the observed spin system. Note that k1 is an apparent pseudo-
first-order rate constant that corresponds to the product of the
second-order association rate constant, kon, and the concentra-
tion of free Cbp, i.e. k1  kon[Cbp]free. The total cross-peak
intensity (IBA(m) IAB(m)) for each time point, m, was fitted
to the sum of the third and forth equalities given in Equation 1
to obtain kex and R1. pA and pB were estimated from the inten-
sity ratio of the monomer and complex peaks in a two-dimen-
sional 1H-15N HSQC spectrum. All NMR data were processed
and analyzed using NMRPipe and Sparky, respectively.
Cells and Gene Transfer—A549 cells were cultured in Dul-
becco’s modified Eagle’s medium (DMEM) supplemented with
10% fetal bovine serum (FBS). Genes were transfected into the
A549 cells using a previously described method (42). In brief,
cDNAs encoding wild-type human Cbp and its mutant, in
which Tyr-296 was substituted with Phe (Y296F) or both Tyr-
296 and Tyr-314 were substituted with Phe (Y296F/Y314F),
were subcloned into the retroviral vectors pCX4puro and
pCX4bleo, respectively. All constructs were generated using a
PCR-based procedure. Retroviral vectors were co-transfected
into Plat-Ewith pGP pE-Ampho (Takara Bio, Japan), which is
an amphotropic retrovirus-packaging construct. Transformed
cell populations were selected with puromycin or bleomycin,
and mixed cell populations were assayed.
Immunoprecipitation and Immunoblotting—Cells were
lysed on ice in 20 mM Tris-HCl (pH 7.4) buffer containing 250
mM NaCl, 0.5 mM EDTA, 2% n-octyl--D-glucoside, 1% Non-
idet P-40, 10% glycerol, 1 mM Na3VO4, 50 mM NaF, and prote-
ase inhibitor mixture and were clarified by centrifugation.
Immunoprecipitation was performed as described previously
(43). In brief, cell lysates were quantified; equal amounts of the
total cell proteins were incubated with anti-Cbp antibody, and
the immune complex was collected on protein G-Sepharose
beads (GE Healthcare). The beads were washed three times in
lysis buffer and boiled in 50l of the SDS sample buffer. Protein
samples were separated by SDS-PAGE, transferred to PVDF
membranes, immunoblottedwith the indicated antibodies, and
subjected to chemiluminescent detection (PerkinElmer Life
Sciences). Anti-human Cbp antibody was generated by immu-
nizing rabbits with a GST-Cbp (residues 331–430) fusion pro-
tein (44). The anti-Src antibody (Ab-1) was purchased from
Calbiochem, anti-Src pY418 antibody fromBIOSOURCE, anti-
Csk antibody from Santa Cruz Biotechnology, and anti-Tyr(P)
antibody (4G10) was from Upstate Biotechnology.
Soft Agar Colony Formation Assay—Single cell suspensions
of 1  104 cells in 1.5 ml of DMEM containing 10% FBS and
0.36% agar were plated onto a layer of 2.5 ml of the same
medium containing 0.7% agar in six-well culture dishes. Viable
colonies were stained with 3-(4,5-dimethylthiazol-2–2-yl)-2,5-
diphenyltetrazolium bromide 10 days after plating. Colonies
larger than0.1 mm in diameter were counted.
RESULTS
Gel Filtration Assay Using Cbp Peptides of Different Lengths—
To identify the Cbp region responsible for the interaction with
Csk, we assayed the interaction between each of the Cbp pep-
tides of different lengths containing Tyr(P)-314 or Tyr-314 and
intact Csk using gel filtration chromatography and SDS-PAGE.
Deletion mutants of Cbp used for the assay, Cbp3 (195–328),
Cbp5 (289–321), Cbp6 (302–321), and Cbp7 (312–321; Fig.
1A), were fused with GST and expressed in E. coli, and intact
Csk was expressed in a baculovirus/insect Sf9 cell system. The
GST-fused Cbp peptides were phosphorylated at Tyr-314 by
addition of recombinant Fyn and ATP.We confirmed that this
reaction did not phosphorylate Tyr-296 by a peptide mass fin-
gerprinting method. Nonphosphorylated Cbp peptides were
prepared as controls by mixing each peptide with Fyn in the
absence of ATP.
Each of the GST-fused peptides, containing Tyr-314 or
Tyr(P)-314, wasmixedwithCsk, and the solutionswere applied
to a gel filtration column. The eluted fractions were applied to
SDS-PAGE to detect the contents. To evaluate the affinity qual-
itatively, we used two types of running buffers in the gel filtra-
tion assay, one containing 150mMNaCl and the other contain-
ing 1 M (NH4)2SO4. The results showed that phosphorylated
Cbp3 andCbp5 eluted from the columnas one peak and formed
a complex with Csk at both salt concentrations, whereas the
nonphosphorylated peptides eluted separately from Csk or
later than the corresponding phosphorylated peptides without
dominantly forming any complexwith Csk (Fig. 1B).Moreover,
the peak corresponding to Csk in the experiment using the
phosphorylated peptides appeared earlier than that using the
nonphosphorylated peptides, indicating that the former eluate
contained Csk of high molecular weight, because of complex
formation with the phosphorylated peptides (Fig. 1B). When
Tyr-314 was not phosphorylated, none of the examined pep-
tides dominantly formed a complex in either salt concentration.
This indicates that the phosphorylation of Tyr-314 is at least
necessary for interaction with Csk. Interestingly, shorter pep-
tides lacking N-terminal regions, namely phosphorylated Cbp6
and Cbp7, formed a complex with Csk during gel filtration in
the running buffer containing 150 mM NaCl but not in the
buffer containing 1 M (NH4)2SO4 (Fig. 1B). Because the inter-
action involving the phosphate group of Tyr(P)-314 was weak-
ened by a high salt concentration, it is expected that this inter-
action is electrostatic in nature. The differences observed in
elusion patterns of Cbp5 and Cbp6 at high salt concentra-
tions indicate that a region within Cbp5 but outside Cbp6
(i.e. 289–302) generates an additional interaction to Tyr(P)-
314 that enables high affinity binding to Csk even at high salt
concentrations.
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FIGURE 1. Gel filtration assay using Cbp peptides of different lengths. A, schematic representation of intact Cbp and its various peptide fragments
that appear in the text. The N- and C-terminal residue numbers are indicated on the left and right of each peptide. Tyr(P) represents the 296th or 314th
phosphorylated Tyr. B, SDS-PAGE of gel-filtered fractions, including GST-fused Cbp3, Cbp5, Cbp6, or Cbp7, and Csk showing a secondary binding region
between Lys-289 (N-terminal of Cbp5) and Ser-302 (N-terminal of Cbp6) on the N-terminal side of the Tyr(P) of Cbp. NP and P indicate the corresponding
nonphosphorylated and phosphorylated Cbp peptides, respectively. Fractions simultaneously containing both the Cbp peptide and Csk indicate that the
complexwas formed in the corresponding condition.Asterisks indicate nonphosphorylated samples.C, SDS-PAGEof gel-filtered fractions, includingGST-fused
Cbp5-Y296F and Csk or GST-fused Csk-SH2, shows that Tyr-296 of Cbp is at least involved in the interaction with Csk or Csk-SH2. NP and P indicate the
corresponding nonphosphorylated and phosphorylated Cbp peptides, respectively. All the gel filtration assayswere performed in a buffer containing 150mM
NaCl (left) or 1 M (NH4)2SO4 (right).
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Gel Filtration Assay Using Y296F Mutant and Phospho-
Tyr-296—Here a question emerged as to which residues
between 289 and 302 mediate the secondary interaction. We
focused onTyr-296 because it is a uniqueTyr in this region, and
we expected its phosphorylation to strengthen the interaction
with Csk in combinationwith phosphorylation of the canonical
Tyr-314. To study the possible secondary interaction region,we
prepared a mutant of GST-fused Cbp5 peptide in which Tyr-
296 was replaced with Phe, and we assayed its interaction with
Csk or Csk-SH2 using gel filtration chromatography as
described above. Although both interactions were maintained
in 150 mM NaCl, they were broken in the presence of 1 M
(NH4)2SO4 (Fig. 1C). As revealed by NMR spectroscopy (see
below), replacement of Tyr-296 with Phe in Cbp5 weakened its
interaction with Csk and Csk-SH2, probably because of the
absence of a hydrogen bond between the hydroxyl group of Cbp
Tyr-296 and the guanidinium group of Csk-SH2 Arg-107.
Overall Structure of theComplex of Csk-SH2withCbp5—The
biochemical data described above, including gel filtration
assays, indicate that Tyr(P)-314 interacts with Csk and that at
least Tyr-296 contributes to binding affinity. To obtain detailed
structural information about this interaction, we have deter-
mined the tertiary structure of the complex of Csk-SH2 with
Cbp5 using multidimensional and multiresonance NMR spec-
troscopy. We confirmed that Csk-SH2 and phosphorylated
Cbp5 (without GST) maintained a stable complex during gel
filtration, whereas Csk-SH2 and nonphosphorylated Cbp5 did
not by MALDI-TOF mass spectrometry. In analysis, we used
not only isotope-labeled Csk-SH2 but also isotope-labeled
Cbp5, which was overexpressed as a GST fusion protein in
FIGURE 2.Comparison of the amino acid sequence of Cbp5with those of various peptide ligands associatedwith SH2domains registered in PDB. The
sequences were aligned using ClustalW2. The sequence of Cbp5 is shown in blue and the Tyr(P) residues in red. A, comparison of Cbp5 with other peptide
ligands associated with different SH2 domains. B, comparison of Cbp5 with other peptide ligands that can interact with Csk-SH2. The secondary binding sites
with Csk-SH2 are shown in orange. C, comparison of the N-terminal sequence from Tyr(P) of Cbp5with the corresponding sequences of other peptide ligands
associated with representative SH2 domains. The secondary binding sites with Csk-SH2 are shown in orange.
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E. coli. Most of the phosphopeptides that have been used to
date for structural analyses were not labeled because they have
often been synthesized chemically as phosphorylated forms.
However, with the isotopically labeled phosphopeptide of Cbp,
we successfully obtained a high quality solution structure of the
complex. TheCbppeptidewas phosphorylated by Fyn andATP
during purification, and its purity was estimated to be	99% by
mass spectrometry. The sequence of Cbp5 includes 33 amino
acid residues, which was much longer in the N-terminal direc-
tion compared with the sequences of various other peptides
that have been used for structural analyses of complexes with
SH2 domains (Fig. 2A). This N-terminal sequence is not con-
served in other ligands that interact with Csk-SH2 (Fig. 2B).
Fig. 3A shows an overlay of the final 20 structures, which
exhibited the best target functions among 100 calculated struc-
tures (PDB code 2rsy). In Fig. 3B, a ribbon diagram of the rep-
resentative structure with the minimum target function is pre-
sented. The coordinates of the backbone atoms of Cbp5 were
well defined in the wide range between Tyr-296 and Lys-319
with respect to the coordinates of Csk-SH2. These gave an aver-
age r.m.s.d. value to themean structure of 0.26
 0.04 Å for the
backbone of Tyr-296–Lys-319 (Cbp) and Met-80–Lys-171
(Csk-SH2; Table 1). Bound Cbp5, regardless of its length, had a
compact conformation comprising an -helix between Glu-
307 andMet-313 and a turn betweenArg-299 andAsp-302 (Fig.
3B).
Conventional Interaction Mode—As shown in Fig. 4A, the
region of Cbp5 that was expected to be specifically recognized
by Csk-SH2, pYSSV, adopted an extended conformation in the
complex. In the conformation, the aromatic and phosphate
groups of Tyr(P)-314 were accommodated in a positively
charged pocket of Csk-SH2. The electrostatic potential of this
pocket was provided by Arg-107 in B and His-128 in D (Fig.
4, B and C). Both residues are conserved in most SH2 domains
and are known to be involved in interactions with phosphoty-
rosines of associated ligands (45). In addition, the phosphate
group of Tyr(P)-314 formed hydrogen bonds with the hydroxyl
group of Ser-109 in B, the amino (–NH2) group of Asn-111 in
C, and the amide group of Tyr-116 through the hydroxyl
group of Thr-117 in C (Fig. 4A). Another intermolecular
hydrogen bond was found between the amide group of the next
FIGURE 3.Overall structure of the complex of Csk-SH2with Cbp5. A, over-
lay of the best 20 structures of Csk-SH2 in complexwith Cbp5. These 20 struc-
tures were selected from 100 structures that were calculated using CYANA-
2.1 with minimum target function values. The structures were fitted with an
r.m.s.d. value of 0.26 
 0.04 Å with respect to the backbone atoms in the
range fromMet-80 to Lys-171 of Csk-SH2 (green) and from Tyr-296 to Lys-319
of Cbp5 (khaki). B, ribbon diagram of the representative structure shows
(coral color) an -helix from Glu-307 to Met-313 and a turn from Arg-299 to
Asp-302.
TABLE 1
Statistics of the final 20 best structures of Csk-SH2 and Cbp (289–321)
NOE upper distance limits
Total 2935
Intraresidue (i j  0) 604
Sequential (i j  1) 779
Medium range (1 i j  	5) 552
Long range (i j 	 5) 1000
Intermolecular 202
Hydrogen bonds 33
Disulfide bond 1
Dihedral angle restraints 230
Distance restraint violations
Number	0.2 Å 0
Mean r.m.s. violations from distance restraints 0.0043
 0.0005 Å
Dihedral angle restraint violations
Number	5° 0
Mean r.m.s. violations from dihedral angle restraints 0.3307
 0.0655°
Ramachandran statistics
Residues in preferred regions 93.4%
Residues in allowed regions 4.8%
Residues in disallowed regions 1.8%
r.m.s deviation to the mean coordinatesa
Backbone atoms 0.26
 0.04 Å
Heavy atoms 0.68
 0.05 Å
a Pairwise r.m.s.d. was calculated for residues 80–172 and 296–318 among 20 re-
fined structures.
FIGURE 4. Conventional interaction mode is observed in the structure of
the complex of Csk-SH2 with Cbp5. A, tube representation of the complex
of Csk-SH2 with Cbp5. Amino acid residues involved in the interaction are
represented using a stick model for Cbp5 and a sphere model for Csk-SH2.
Hydrogen bonds are shown as cyan lines and those around Tyr(P)-314 are
highlighted with dotted circles. Amino acid residues of Cbp5 and Csk-SH2 are
labeled in orange and black, respectively. B,binding pockets on the surface of
Csk-SH2 with residues around Tyr(P)-314 and Val-317 of Cbp5. The electro-
static potentialwas calculatedusingDelphi andmappedon the surfaceof the
structure of Csk-SH2. Positive and negative charges are indicated in blue and
red, respectively. C, Arg-107 and His-128 of Csk-SH2, which generates the
positive charge around Tyr(P)-314, interact with the phosphate group of
Tyr(P)-314 in the conventional manner.
New SH2Domain BindingMode of Csk to Cbp/PAG
15246 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 288•NUMBER 21•MAY 24, 2013
 at O
SA
K
A
 U
N
IV
ERSITY
 on N
ovem
ber 10, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
(Tyr(P)1) residue Ser-315, and the carbonyl group ofHis-128.
The (Tyr(P)3) residue Val-317 was accommodated in a
pocket containing Ile-140 and Leu-163 through hydrophobic
interactions (Fig. 4, A and B). This binding mode was the same
as that commonly observed for other SH2 domains and their
associated phosphopeptides (1, 46–49).
Another Novel Interaction Region between Csk-SH2 and
Cbp5—Consistent with the results of our gel filtration experi-
ments, structure determination of the complex revealed an
additional interaction region in the N-terminal direction from
Tyr(P)-314 of Cbp5 (Fig. 5). This region contained a unique
-helix between Glu-307 andMet-313 and a hydrophobic core
comprising aliphatic Lys-297 and Arg-299 and side chains of
Leu-305, Ile-310, and Met-313. The hydrophilic side chains of
Lys-297, Arg-299, Glu-301, Asp-302, Glu-307, Glu-308, and
Glu-309 were exposed to the solvent (Fig. 5B). In addition, the
residues ranging from Arg-299 to Asp-302 took a turn confor-
mation that exposed the hydrophilic side chains of Glu-300,
Glu-301, and Asp-302 to the solvent. In the structure of Cbp5,
at least in its complex with Csk-SH2, Tyr-296 and Tyr(P)-314
were positioned such that both side chains were inserted
together into the pocket of Csk-SH2 with their aromatic rings
arranged side by side (Fig. 5C). Most regions (99
 1%) of Tyr-
296 were buried in the interior of the complex structure, and
the accessible surface area of its main chain and side chain was
1 
 1 (%). This is in contrast to the accessible surface area of
Tyr-296 in the free state, which is 30
 3 (%). Fig. 5D shows the
residues of Csk-SH2 that were involved in the interaction with
Tyr-296. The position of the Tyr-296 hydroxyl group allowed
electrostatic interactions with Csk-SH2 via the phosphate
group of Tyr(P)-314, the main-chain amide group of Thr-110,
and themain-chain amide and side-chain amino groups ofAsn-
111. It also formed a hydrogen bond with the guanidinium
group of Arg-107. These data explain the decreased affinity
observed in gel filtration experiments when Tyr-296 was
replacedwith Phe lacking this hydroxyl group. Phosphorylation
of Tyr-296 caused decreased affinity between Cbp and Csk-
SH2, probably because of steric hindrance and electrostatic
repulsion of bulky negatively charged phosphate groups on
Tyr-296 and Tyr-314. In addition, the complex structure
revealed van derWaals contacts betweenArg-299/Glu-300 and
Thr-110/Asn-111, and the filtered NOESY experiments exhib-
ited strong intermolecular NOE peaks between these residues.
These data indicate that Arg-299 andGlu-300 are also involved
in the interaction (Figs. 5E and 6).
We compared the two-dimensional 1H–15N HSQC spectra
of Csk-SH2 before and after complex formation (Fig. 7A) and
plotted chemical shift differences against the amino acid
sequence (Fig. 7B). No significant difference was observed in
the overall peak distribution in the spectra. However, Thr-110
and Asn-111 exhibited the weighted average chemical shift
deviations over 1.0 ppm (Fig. 7B). These data correspond to
interactions of Thr-110 with Tyr-296 and Arg-299 as well as
Glu-300 of Cbp and Asn-111 with Tyr-296, Arg-299, and
Tyr(P)-314 ofCbp (Figs. 4 and 5). Becausewe labeledCbp5with
isotopes, we compared the two-dimensional 1H-15N HSQC
spectra of Cbp5 before and after complex formation (Fig. 7C)
and plotted chemical shift differences against the amino acid
sequence (Fig. 7D). The complex formation led to a wider dis-
tribution of Cbp5 amide 1H-15N cross-peaks (Fig. 7C). In par-
ticular, Lys-297 exhibited a chemical shift change as large as 1.0
ppm (Fig. 7D). The structure of the complex indicated a hydro-
FIGURE 5. Another interaction region found in the structure of the complex of Csk-SH2 with Cbp5. A, interaction region between Csk-SH2 and Cbp5 is
circled in black in the ribbondiagramof the complex of Cbp5with Csk-SH2. Amino acid residues involved in the interaction are represented using a stickmodel.
B, Cbp5 exhibits an amphipathic character, with hydrophilic residues exposed to the solvent and hydrophobic residues and aliphatic chains oriented inward.
Positively and negatively charged residues are labeled in cyan and red, respectively, and hydrophobic residues are labeled in black. C, Tyr-296 and Tyr(P)-314
of Cbp5 (in khaki) are accommodated in the binding pocket of Csk-SH2. The two residues are represented using a stick model. An -helix and a turn of Cbp
formed on Csk-SH2 bring the two Tyr residues close to each other. D, residues of Csk-SH2 interacting electrostatically with the hydroxyl group of Tyr-296.
Hydrogenbonds are shownby cyan lines. Amino acid residues of Cbp5 andCsk-SH2 are labeled in orange and black, respectively. E, residues additionally found
as contributors to the second interaction site. Amino acid residues of Cbp5 and Csk-SH2 are labeled in orange and black, respectively. Hydrogen bonds are
shown as cyan lines. Csk-SH2 is shown in green and Cbp5 in khaki.
New SH2Domain BindingMode of Csk to Cbp/PAG
MAY 24, 2013•VOLUME 288•NUMBER 21 JOURNAL OF BIOLOGICAL CHEMISTRY 15247
 at O
SA
K
A
 U
N
IV
ERSITY
 on N
ovem
ber 10, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
gen bond between the carbonyl group in the main chain of
Lys-297 and the amino group of the side chain of Asn-111,
indicating that Lys-297 also contributes to the interaction of
Cbp5 with Csk-SH2 (Fig. 5E). Among known ligands of SH2
domains, no residues that correspond to Tyr-296, Lys-297,
Arg-299, and Glu-300 of Cbp and Thr-110 or Asn-111 of
Csk-SH2 are definitely conserved (Fig. 2C). Likewise, in
other SH2 domains, the residues that correspond to Thr-
110 and Asn-111 are various and not conserved as expected
(45).
FIGURE 6. Intermolecular NOEs observed for Arg-299 or Glu-300 and those for Ser-315 or Ser-316. The latter two residues are involved in thewell known
canonical binding to Csk-SH2. The corresponding regions are shown from a 13C,15N-filtered, 15N-edited NOESY spectrum of 13C,15N-labeled Cbp5 in complex
with unlabeled Csk-SH2. The peak intensities represent the peak heights of the corresponding residues, as estimated by Sparky.
FIGURE 7.Chemical shift perturbation experiments of [15N]Csk-SH2or [15N]Cbp5 in the complex. indicates theweighted chemical shift deviation that
was calculated according to the following equation:  ((H)2/2 (N/5)2/2)1/2, where H and N indicate the chemical shift changes of the amide
proton and nitrogen, respectively. A, overlay of the two-dimensional 1H-15N HSQC spectra of [15N]Csk-SH2 with (orange) and without (cyan) unlabeled Cbp5.
B, chemical shift differences of the two spectra are plotted against the residue number. The peaks that showed	1.0 ppm changes are highlightedwith a blue
circle. C, overlay of the two-dimensional 1H-15N HSQC spectra of [15N]Cbp5 with (orange) and without (cyan) unlabeled Csk-SH2. D, chemical shift differences
of the two spectra are plotted against the residue number. The peak that showed1.0 ppm change is highlighted with a blue circle.
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Involvement of Tyr-296 in the Cbp-Csk Interaction in Cells—
To evaluate the physiological role of Tyr-296 in stabilizing the
Cbp-Csk interaction, we examined the function of a Cbp
mutant (Y296F)with a substitution of Tyr-296 by Phe in human
lung cancer A549 cells with marked up-regulation of c-Src.We
have recently shown that the expression of Cbp is extensively
down-regulated in these cells and that the re-expression of Cbp
inactivates c-Src and suppresses tumor growth by facilitating
the recruitment of Csk to the membrane (44). In Cbp-express-
ing cells, the Cbp-Csk interaction was readily detected by
immunoprecipitation (Fig. 8A). However, in mutant cells,
Y296F bound very weakly to Csk. Furthermore, a double
mutant, in which Tyr-296 and Tyr-314 were replaced with Phe
(Y296/314F), completely failed to interact with Csk. Inversely,
the Tyr phosphorylation levels of Cbp, which reflect the activa-
tion status of c-Src, were significantly augmented when Cbp
mutants were expressed. These observations demonstrate that
Tyr-296 contributes to stabilizing the Cbp-Csk interaction
even in cells. We next assessed the role of Cbp in cellular func-
tion by examining the effects of the expression of Cbp on the
colony-forming ability of tumor cells. As described previously,
the expression of Cbp significantly suppressed colony forma-
tion in A549 cells (Fig. 8B). However, this growth suppression
was significantly attenuated when Y296F was expressed. The
expression of Y296/314F did not induce significant suppression
of the colony-forming ability of these cells, revealing that Tyr-
296 supports the tumor-suppressive function of Cbp by stabi-
lizing the Cbp-Csk interaction.
Interestingly, another mutant, in which Tyr-296, Lys-297,
Arg-299, and Glu-300 were replaced with Ala (AASAA), atten-
uated growth suppressionmore thanY296F did. This effect was
comparable with that of mock and Y314F despite retention of
Tyr-314, which is critical for the Cbp-Csk interaction (Fig. 8C).
As described above, these residues in the wild-type specifically
interact with Thr-110 or Asn-111 of Csk-SH2 and form the
core of the second interaction region. Hence, it is clear that
simultaneous replacement of all of these residues inAASAA led
to decreased Csk-binding affinity and that the second recogni-
tion region is at least required for tumor suppression via the
Cbp-Csk interaction.
Cbp Binding to the SH2 Domain Changes Its Structure to the
More Active Form—Previous x-ray analyses of intact Csk dem-
onstrated crystal structures of both active and inactive forms,
which probably establish an equilibrium in solution (14). Thus,
in order for Csk to be completely active, its conformation must
shift to the active form and be maintained at least during the
kinase reaction. Interestingly, past experiments showed that
Csk activity increased upon interaction with a Cbp phospho-
peptide consisting of only six residues (AMpYSSV) or 10 resi-
dues (ISAMpYSSVNK) (13, 16–19). However, overlaying the
solutionstructureof thecomplexon intact crystal structuresof the
free form showed that the Cbp5 peptide was distant from the cat-
alytic domain (Fig. 9A). Therefore, it is conceivable that the cata-
lytic domain is activated through a possible conformational
change in Csk-SH2 triggered by Cbp binding to it.
To investigate how the effect of Cbp binding is structurally
transmitted to the SH2domain, we examined the chemical shift
perturbation observed for Csk-SH2 upon binding with Cbp5.
Thus, mapping of the perturbed residues on the structure of
Csk-SH2 suggested that its B/C loop and D strand under-
went conformational or dynamic changes followingCbp5 bind-
ing (Fig. 10A). We next compared the structure of Csk-SH2 of
the complex with the crystal structure of the free form, which
had previously been determined by x-ray analysis (PDB code
3EAC). Consistent with the above-mentioned chemical shift
changes, these structures in the B/C loops were distinctly
different from each other (Fig. 10A). Furthermore, in our com-
plex structure, hydrogen bonds were found in the B/C loop
around Tyr(P)-314, including those between the amide group
of Ser-109 and the carbonyl group of Asp-115, the hydroxyl
group of Ser-109 and the amide group of Tyr-112, and the car-
bonyl group of Tyr-112 and the amide group of Asp-115 (Fig.
FIGURE 8. Tyr-296 is required for a stable Cbp-Csk interaction and tumor-suppressive function of Cbp. A, whole cell lysates (WCL) from A549 cells and
Cbp-expressing wild-type cells, Y296F mutant, and Y296F/Y314F double mutants were immunoblotted with the indicated antibodies. Cbp was then immu-
noprecipitated (IP) from whole cell lysates with anti-Cbp and then immunoblotted with the indicated antibody. Asterisks indicate the location of the immu-
noglobulin. B, effects of the expression of Cbp and its YFmutants on the tumor growth of A549 cells were examined using colony formation assays in soft agar.
Colonies were stained with 3-(4,5-dimethylthiazol-2–2-yl)-2,5-diphenyltetrazolium bromide 10 days after plating. The colony numbers per cm2 are presented
asmean
 S.E. from three independent experiments. C, effects of the expression of Cbp and anothermutant, AASAA, on the tumor growth of A549 cells were
examined as described in B. The mutated amino acids are shown in bold letters in the sequence above the graph.
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10B). The presence of these hydrogen bonds was supported by
intramolecular NOEs between these residues (Fig. 9B). Inter-
estingly, these were also observed in the crystal structure of the
active form (Fig. 10C). The complex structure also showed that
the phosphate group of Tyr(P)-314 forms hydrogen bonds with
Ser-109 and Asn-111 as well as with Tyr-116 through the
hydroxyl group of Thr-117 (Fig. 10B). It is noteworthy that the
novel binding sites, Tyr-296, Lys-297, Arg-299, and Glu-300, of
Cbp bound with Thr-110 and Asn-111 in the same B/C loop
of Csk-SH2 (Fig. 5, D and E). These novel binding sites appar-
ently contribute to maintenance of a network of hydrogen
bonds around the B/C loop, with the phosphate group of
Tyr(P)-314 as the center.
In contrast, these hydrogen bonds were not observed in the
crystal structure of the inactive form. The residue pairs in the
B/C loop in the inactive form are too distant to form such
hydrogen bonds. Thus, the structure of Csk-SH2 in complex
with Cbp5wasmore similar to the crystal structure of Csk-SH2
in the active form than to the one in the inactive form (Fig. 10,C
and D). Taken together, these observations show that Cbp
binding to the SH2 domain generated a hydrogen bond net-
work around the B/C loop, shifting its conformation to the
more active form.
NMRRelaxationAnalysis—To evaluate changes in the struc-
tural dynamics of Csk-SH2 induced by Cbp binding, we meas-
ured 15N R1 and R2 relaxation rates, and {1H}-15N steady-state
NOE values of uniformly 15N-labeled Csk-SH2 with and with-
out uniformly 15N-labeled Cbp5 peptide. Resonances showing
severe overlap or low intensity were excluded from the study.
The average rotational correlation time mwas estimated as 5.8
and 8.4 ns for Csk-SH2 in the free and complex forms, respec-
tively. Using these relaxation data, we analyzed residue-specific
internal motions of Csk-SH2 in the two forms in terms of the
order parameters squared (S2) by themodel-free approach (Fig.
11, A and B). Fig. 11C shows the difference between the S2
values of Csk-SH2 with and without Cbp5. The two forms of
Csk-SH2 exhibited no significant difference in overall dynam-
ics. The average S2 values for Trp-82–Val-172 of Csk-SH2were
0.85 
 0.01 (one S.D.) in the free form and 0.83 
 0.01 in the
complex form. However, the S2 values in loop regions exhibited
significant differences between the two forms. In particular,
Leu-86 in the N-terminal region, Ser-136 in the D/E loop
(turn), Asp-141 in the E/F loop, and Gly-162 in the B/G
loop had S2 values that were 0.1 less in the bound form. In
contrast, Ser-109 and Asn-111 in the B/C loop and Asp-161
FIGURE9.ConnectionbetweenCbp5andthekinasedomain throughCsk-
SH2.A, relative configuration betweenCbp5 and the kinase domain revealed
by overlaying of the solution structure of Csk-SH2 in complex with Cbp5 and
the crystal structure of intact Csk (PDB code 1K9A). Csk-SH2 and Cbp5 in the
complex are colored in green and khaki, respectively, and intact Csk is colored
in gray. The region corresponding to C is shown with a black square. B, intra-
molecular NOEs observed among Ser-109, Tyr-112, and Asp-115 supporting
the presence of the hydrogen bonds between them. The corresponding
regions are shown froma 15N-editedNOESY spectrumof 15N-labeledCsk-SH2
in complexwith unlabeledCbp5.C, insertion of Ala-228 into the hydrophobic
pocket formed by Tyr-116, Tyr-133, Leu-138, and Leu-149, as observed in the
crystal structure of Csk. These residues are shown with a stick model. The
pocket is highlighted with a brown circle.
FIGURE 10. Characterization of the structure of Csk-SH2 in complex with
Cbp5. A, mapping of the chemical shift deviations in Csk-SH2 upon binding
with Cbp5 on the structure of Csk-SH2 and comparison of the solution struc-
ture of Csk-SH2 of the complex with the crystal structure of the free form
(gray; PDB code 3EAC). The residues with weighted chemical shift deviations
larger than 0.8 ppm are colored in red; those between 0.8 and 0.4 ppm are
reddish orange, and those between 0.4 and 0.3 ppm are orange. Pro residues
are colored in black. Both Tyr-116 and Tyr-133, which are involved in the
hydrophobic pocket in contact with Ala-228 in the kinase domain of active
Csk (Fig. 9), underwent significant chemical shift changes that were not due
to direct contact with Cbp5. B, hydrogen bond network generated between
Tyr(P)-314 of Cbp5 and its nearby residues in the B/C loop of Csk-SH2. The
side chains of these residues are represented by a stickmodel and hydrogen
bonds are shown as blue lines. Amino acid residues of Cbp5 and Csk-SH2 are
labeled inorangeandblack, respectively.C, comparisonbetween the solution
structures of the complex of Csk-SH2 with Cbp5 (green) and the crystal struc-
ture of intact Csk-SH2 in the active form (gray; PDB code 1K9A). Hydrogen
bonds are shown as cyan lines. The r.m.s.d. value of the heavy atoms in the
main chainswas 0.81 Å.B/C loops, which have almost the same conforma-
tion in both structures, are highlighted with black squares. D, comparison
between the solution structure of the complex and the crystal structure of
intact Csk-SH2 in the inactive form (PDB code 1K9A). The r.m.s.d. value of the
heavy atoms in the main chains was 0.92 Å. B/C loops, indicated with a
double-headed arrow, take different conformations in the two structures.
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in the B/G loop had greater S2 values (about 0.1) in the
bound form. These differences are mapped on the structure of
Csk-SH2 (Fig. 11D). The S2 values of Cbp5 in the complex
exceeded 0.65 (mean; 0.80 
 0.01) over the range of 22 amino
acids from Tyr-297 to Asn-318 (Fig. 11D). These data indicate
that a wide range of the region, including a secondary interac-
tion site, stably bound with Csk-SH2.
zz-Exchange Spectroscopy—To evaluate the affinity of Csk-
SH2 for the secondary binding site of Cbp, we performed zz-
exchange spectroscopy of 15N-labeled Csk-SH2 mixed with
each of Cbp5, Cbp6, andCbp7. Kinetic datawere analyzed from
well resolved peaks of two residues: Gly-162, which binds
directly to Cbp, andVal-172. AlthoughVal-172 is located at the
opposite side of the binding region, it exhibited an NMR peak
pattern similar to that of Gly-162 because of a possible small
conformational change synchronized with Cbp binding. As a
result, Cbp5, the longest peptide that includes the secondary
binding site, exhibited distinctly lower exchange rates (koff 
0.80 s1 for Gly-162), whereas both Cbp6 and Cbp7 exhibited
8–25 times higher koff values for Gly-162 (koff 6.69 s1 for
Cbp6 and koff  23.1 s1 for Cbp7) (Table 2). These results
evidently indicated that longer peptides interacted more
strongly and that Cbp5 had the highest affinity because of the
additional interaction, which Cbp6 and Cbp7 lack.
DISCUSSION
It is generally accepted that SH2 domains bind to ligands by
specifically recognizing aTyr(P) alongwith the1 to3 amino
acid residues that follow in the C-terminal direction. Our com-
plex structure of Csk-SH2 with Cbp5 showed that Tyr(P)-314
of Cbp and the three residues that follow toward theC terminus
interacted with Csk-SH2 in the same manner as observed in
many other phosphopeptides that interact with normal SH2
domains. This observation was supported by our gel filtration
experiments and indicates that Csk-SH2 is a normal SH2
domain thatmediates typical interaction patterns.However, we
have identified a novel binding region of Cbp with Csk-SH2.
Analyses of intermolecular NOE and 15N-spin relaxation
rates indicated that the region of Cbp that interacts with
Csk-SH2 spans the 23 amino acid residues between Tyr-296
and Asn-318.
Even when nonlabeled Csk-SH2 was added to a solution of
nonphosphorylated [15N]Cbp5, the two-dimensional 1H–15N
HSQC spectrum of Cbp5 exhibited neither chemical shift
changes nor signal broadening in its amide resonance peaks.
None of the amide peaks that were assigned to a region close to
Tyr-296 in the sequence underwent any chemical shift pertur-
bation either. This indicates that the novel N-terminal interac-
tion region of Cbp alone is not sufficient to enable Cbp5 to bind
to Csk-SH2. In fact, addition of a phosphate group to Tyr-314
induced amide chemical shift changes of not only Tyr-314 but
also Asp-302 and Lys-289, which are distant from Tyr-314 in
the context of the amino acid sequence. In addition, our pre-
liminary molecular dynamic simulation suggested a bent con-
formation of Cbp5, with Tyr(P)-314 close to Tyr-296 even in its
FIGURE 11. Relaxation analyses of 15N-labeled Csk-SH2 of the free and complex form and 15N-labeled Cbp5 of the complex form. The data were
obtainedat a 15N resonance frequencyof 50.68MHz,which corresponded to a 1H resonance frequencyof 500.13MHz. These relaxationdata indicate that Cbp5
in the complex takes a stable conformation across a wide range that includes the N-terminal region from Tyr(P) (residues between Tyr-296 and Asn-318). A–C,
plots of thegeneralizedorder parameter squared (S2) obtained from themodel-free analysis of the 15N-spin relaxation rates and {1H}-15N steady-stateNOEdata
at 11.7 tesla for Csk-SH2 (A) and Cbp5 (B) and of the changes in S2 induced by Cbp-binding (S2 S2complex S
2
free) (C) as a function of residue number.Open
diamonds correspond to the free form of Csk-SH2 and filled diamonds the complex form of Csk-SH2 and Cbp5. D,mapping of the changes in the generalized
order parameter squared inducedby Cbp-binding (S2) on the structure of Csk-SH2. Positive to negative changes are gradually colored in blue to red. Residues
showing S2 above0.09 or below0.09 are colored in blue or red, respectively.
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free state, rather than a randomly fluctuating extended confor-
mation as often seen in short peptides (data not shown). Thus,
there may be interference between Tyr-314 and Tyr-296, and
when Tyr-314 is not phosphorylated, Tyr-296 may also fail to
interact with Csk-SH2. In either case, the result shows that
phosphorylation of Tyr-314 dominantly controls association
and dissociation with Csk-SH2.
Although the second binding region containing Tyr-296 cer-
tainly contributes to the interaction, it appears to enhance the
selectivity of Csk-SH2 for this ligand. Intact Cbp possesses six
Tyr residues that can undergo phosphorylation (13). Among
them, the three residues following Tyr-224 (pYASV) are almost
the same as those followingTyr-314 (pYSSV) except forAla and
Ser at the 1 position in the respective sequences. In fact,
another ligand for Csk-SH2, SIT, possesses this pYASV
sequence as the binding site (50). In addition, the short peptide
GDGpYXXXSPLLL, inwhich pYXXX corresponds to any of the
sequences pY(T/A/S)(K/R/Q/N)(M/I/V/R), is reportedly rec-
ognized byCsk-SH2 (51). Furthermore, sequential alignment of
Cbp5 with other ligands containing Tyr(P) residues showed
that theN-terminal interaction region around Tyr-296 of Cbp5
is unique and that the corresponding regions are rich in variety
in the sequences of other ligands (Fig. 2B). These results indi-
cate that the sequence that includes a few residues following
Tyr(P)-314 is too short to ensure strict selectivity by Csk-SH2.
Through much discussion of the specificity of many SH2
domains and corresponding ligands, it has been concluded that
SH2 domains generally have no distinctive selectivity for short
ligands (52). However, this type of discussion has been based on
peptide ligands that include about 10 amino acids as the longest
region (2, 51, 53), probably because such short regions of pep-
tides, exclusively analyzed by x-ray crystallography or NMR,
take particularly rigid conformations in complex with corre-
sponding SH2 domains. In reality, however, a region other than
that containingTyr(P)may contribute to the specificity of bind-
ing and may play an essential role in the biological and physio-
logical function of each SH2 domain, as demonstrated by the
complex structure of Csk-SH2 and Cbp5. Indeed, it is reported
that the SH2 domain of phospholipase C recognizes a region
of the ligand wider than the conventional recognition sequence
(54). Such wide range recognition is expected as a common
characteristic of SH2 domains once longer peptide ligands or
intact proteins are examined in structural analyses of these
complexes.
According to a sequence alignment of various SH2 domains,
including Csk-SH2, a part of the additional interaction region
found in Csk-SH2 (Thr-110 and Asn-111 in the B/C loop) is
unique to Csk-SH2 and is not conserved in other SH2 domains
(45). Interestingly, it is reported that the N-terminal SH2
domain of phospholipase C interacts with the activated Tyr
kinase domain of FGFR1. This occurs through Thr-590–Val-
592 residues in the B/C loop of the SH2 domain as a second-
ary binding sitewithGln-606, Asp-755, Val-758, andAla-759 of
FGER1 (54). This region in the B/C loop matched the one
thatwe identified as the secondary interaction site in our exper-
iments. In particular, Thr-590 of phospholipase C-SH2 struc-
turally corresponded to Asn-111 of Csk-SH2. Furthermore, in
various ligands of SH2domains, the residues that corresponded
to Tyr-296, Lys-297, Arg-299, and Glu-300 of Cbp that inter-
acted with Thr-110 or Asn-111 of Csk-SH2 are definitely not
conserved (Fig. 2C). Taken together, residues in the B/C
loops inmany other SH2domainsmay also be involved in inter-
actions with their ligands, and the versatility of the residues in
these loops may enhance the ligand specificity of each SH2
domain.
A two-dimensional 1H-15N HSQC spectrum of Cbp5 in the
free form exhibited most of the main-chain amide signals
crowding within a 1H resonance range between 8.0 and 8.5
ppm, suggesting that no distinct conformation exists domi-
nantly in the free state of Cbp (Fig. 5C). Although, as described
above, particular conformations may be taken, these are unsta-
ble. However, Cbp5 in the complex state had a hydrophobic
core (Leu-305, Ile-310, and Met-313 and the aliphatic parts of
Lys-297 and Arg-299) and hydrophilic residues on the surface
(Lys-297, Arg-299, Glu-301, Asp-302, Glu-307, Glu-308, and
Glu-309) and was stabilized by adopting a characteristic con-
formation (Fig. 5B). These characteristics eluded studies of
shorter peptide ligands in complex with SH2 domains. Impor-
tantly, this structural compaction allowed the Cbp5 peptide to
interact with a limited region in the B/C loop of Csk-SH2, in
which a characteristic hydrogen bond network was observed.
Our NMR study revealed that Cbp binding to Csk-SH2
formed a hydrogen bond network around the B/C loop, with
the phosphate group of Tyr(P)-314 as the center. According to
the crystal structure of intact Csk in the active form, Tyr-116 in
this hydrogen bond network forms a hydrophobic pocket with
Tyr-133, Leu-138, and Leu-149 that interacts with the catalytic
domain through the methyl group of Ala-228 (Fig. 9C). How-
ever, these residues are geometrically distant fromeach other in
the inactive form. Interestingly, a recent study reported that any
mutation in Tyr-116, Leu-138, or Leu-149 in the hydrophobic
pocket or in Ala-228 in the kinase domain to Ala or Gly
decreases Csk activity to 10–20%of thewild type in the absence
and presence of a Cbp peptide (18). These experiments demon-
strate that binding of Ala-228 to this hydrophobic pocket is
essential for Csk activation. Cumulatively, these observations
TABLE 2
Chemical exchange parameters of Csk-SH2 in the presence of Cbp5, Cbp6, or Cbp7
Peptide SH2 pB/pA koff kex R1
s1 s1 s1
Cbp5 Gly-162 1.04
 0.02 0.80
 0.05 1.65
 0.10 1.66
 0.09
Val-172 0.86
 0.08 1.78
 0.15 1.69
 0.13
Cbp6 Gly-162 1.22
 0.02 6.69
 0.37 15.0
 0.8 1.13
 0.04
Val-172 6.72
 0.69 15.1
 1.5 1.23
 0.06
Cbp7 Gly-162 0.90
 0.05 23.1
 3.2 44.0
 5.6 1.56
 0.07
Val-172 16.4
 6.0 31.2
 11.4 1.24
 0.13
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suggest that a hydrogen bond network between Tyr(P)-314,
probably involving the novel binding sites, of Cbp and the
above-mentioned residues in Csk-SH2 maintains the active
form, stabilizes packing between the hydrophobic pocket,
including Tyr-116 of the SH2 domain and Ala-228 in the cata-
lytic domain, and consequently leads to allosteric activation of
Csk (Figs. 10B and 9C).
In conclusion, we determined the solution structure of the
complex of Csk-SH2 with Cbp. This structure revealed the
presence of a novel binding region in Cbp that is separate from
the canonical binding region. Furthermore,mutational analysis
in cells showed that both canonical and novel binding sites are
required for tumor suppression via the Cbp-Csk interaction.
These findings indicate that conventionally known interaction
sites in target ligands do not explain the biological functions of
the associated SH2 domains alone.
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